About
Chen Schor is a biopharmaceutical executive who serves as President, Chief Executive Officer, and director of Adicet Bio, a public cell-therapy company focused on gamma delta CAR-T therapies for cancer and autoimmune disease. He previously co-founded and led resTORbio and has held senior operating roles at Synta Pharmaceuticals, Novalere FP, Eleven Biotherapeutics, and Teva Pharmaceuticals. His public affiliations also include board roles with Alliance for Cancer Gene Therapy, Karyopharm Therapeutics, and Carbon Biosciences, plus earlier partnership experience at Yozma Venture Capital.
Areas of interest
biotechcell therapycancer immunotherapygamma delta CAR-Tautoimmune diseaseoncologygene therapyaging biologybiopharma business development